Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-20T01:22:33.639Z Has data issue: false hasContentIssue false

Cost analysis of osteoradionecrosis

Published online by Cambridge University Press:  26 January 2017

L Park*
Affiliation:
Department of Otolaryngology Head and Neck Surgery, North Shore Hospital, Auckland, New Zealand
N Lilic
Affiliation:
Department of Otolaryngology Head and Neck Surgery, Auckland City Hospital, New Zealand
B Addison
Affiliation:
Department of General Surgery, North Shore Hospital, Auckland, New Zealand
R Patel
Affiliation:
Department of Otolaryngology Head and Neck Surgery, Auckland City Hospital, New Zealand
*
Address for correspondence: Ms Lydia Park, 7 Dexter Avenue, Mount Eden, Auckland, New Zealand Fax: +64 9 631 0716 E-mail: Lydiapark88@hotmail.com

Abstract

Objective:

Osteoradionecrosis is a significant complication of head and neck cancer treatment, and its most severe form (grade III) necessitates radical surgery. This study aimed to compare the cost of free-flap reconstructive surgery for grade III osteoradionecrosis and similar non-osteoradionecrosis cases in order to assess the cost burden of osteoradionecrosis treatment.

Methods:

All patients who underwent free-flap reconstructive surgery for osteoradionecrosis between July 2004 and July 2010 at Auckland City Hospital (19 patients) were identified, and relevant data were collected retrospectively. These patients were matched in terms of age and sex with patients who underwent free-flap reconstructive surgery.

Results:

The treatment cost was 44 per cent higher in osteoradionecrosis patients when compared to non-osteoradionecrosis patients.

Conclusion:

The significant financial burden on the health system, and the growing evidence for the effectiveness of pentoxifylline, tocopherol and clodronate, should prompt us to explore this alternative treatment further.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Madrid, C, Abarca, M, Bouferrache, K. Osteoradionecrosis: an update. Oral Oncol 2010;46:471–4CrossRefGoogle ScholarPubMed
2 Marx, RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 1983;41:283–8Google Scholar
3 Delanian, S, Lefaix, JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol 2004;73:119–31Google Scholar
4 Pitak-Arnnop, P, Sader, R, Dhanuthai, K, Masaratana, P, Bertolus, C, Chaine, A et al. Management of osteoradionecrosis of the jaws: an analysis of evidence. Eur J Surg Oncol 2008;34:1123–34Google Scholar
5 Annane, D. Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol 2004;22:4893–900Google Scholar
6 Dion, MW, Hussey, DH, Doornbos, JF, Vigliotti, AP, Wen, BC, Anderson, B. Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis. Int J Radiat Oncol Biol Phys 1990;19:401–7CrossRefGoogle ScholarPubMed
7 Delanian, S, Depondt, J, Lefaix, JL. Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial. Head Neck 2005;27:114–23Google Scholar
8 Delanian, S, Chatel, C, Porcher, R, Depondt, J, Lefaix, JL. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial. Int J Radiat Oncol Biol Phys 2011;80:832–9CrossRefGoogle ScholarPubMed
9 Cannady, SB, Dean, N, Kroeker, A, Albert, T, Rosenthal, E, Wax, M. Free flap reconstruction for osteoradionecrosis of the jaws – outcomes and predictive factors for success. Head Neck 2011;33:424–8CrossRefGoogle ScholarPubMed
10 Kelishadi, SS, St-Hilaire, H, Rodriquez, ED. Is simultaneous surgical management of advanced craniofacial osteoradionecrosis cost-effective? Plast Reconstr Surg 2009;123:1010–17CrossRefGoogle ScholarPubMed
11 Smith, GC, Pell, JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 2003;327:1459 CrossRefGoogle ScholarPubMed
12 Potts, M, Prata, N, Walsh, J, Grossman, A. Parachute approach to evidence based medicine. BMJ 2006;333:701–3Google Scholar